碘对比剂全程化药学服务共识

中国医药教育协会临床合理用药专业委员会; 广东省药学会用药评价与临床科研专家委员会

doi:10.6039/j.issn.1001-0408.2024.01.01

您当前的位置：

首页 >

文章列表页 >

碘对比剂全程化药学服务共识

指南与共识 | 更新时间：2024-01-11

- 碘对比剂全程化药学服务共识
- Consensus on whole-process pharmaceutical care for iodine contrast medium
- 中国药房 2024年35卷第1期页码：1-9
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2024.01.01
  中图分类号： R95;R981
- 纸质出版日期：2024-01-15，
  
  收稿日期：2023-08-08，
  
  修回日期：2023-11-27，
扫描看全文
中国医药教育协会临床合理用药专业委员会,广东省药学会用药评价与临床科研专家委员会.碘对比剂全程化药学服务共识[J].中国药房,2024,35(01):1-9.

.Consensus on whole-process pharmaceutical care for iodine contrast medium[J].ZHONGGUO YAOFANG,2024,35(01):1-9.
中国医药教育协会临床合理用药专业委员会,广东省药学会用药评价与临床科研专家委员会.碘对比剂全程化药学服务共识[J].中国药房,2024,35(01):1-9. DOI： 10.6039/j.issn.1001-0408.2024.01.01.

.Consensus on whole-process pharmaceutical care for iodine contrast medium[J].ZHONGGUO YAOFANG,2024,35(01):1-9. DOI： 10.6039/j.issn.1001-0408.2024.01.01.

摘要

目的

探讨碘对比剂全程化药学服务模式，促进碘对比剂的临床合理使用。

方法

中国医药教育协会临床合理用药专业委员会和广东省药学会用药评价与临床科研专家委员会组织国内专家，成立《碘对比剂全程化药学服务共识》工作组，针对碘对比剂的发展历程、适应证、禁忌证、不良反应、药物相互作用、特殊人群用药、药学服务等进行文献检索、循证分析和研讨，梳理全程化药学服务的内容与流程，最终形成共识。

结果

制定的碘对比剂全程化药学服务共识包括检查前对患者、肾功能、合并用药和水化方案的评估，检查中有无发生对比剂外渗或发生（可疑）急性不良反应，检查后的观察时间点和随访等内容，以药学服务流程图展示各阶段的具体工作，并形成用药监护记录表用以记录工作情况。

结论

本共识构建了碘对比剂全程化药学服务体系，为临床医生、护理人员合理使用该类特殊药品提供了科学依据，也为药师进行相关药学服务提供了参考。

Abstract

OBJECTIVE

To explore the whole-process pharmaceutical care model of iodine contrast medium and promote the rational clinical use of iodine contrast medium.

METHODS

Clinical Professional Committee on Rational Drug Use of China Medical Education Association and Expert Committee on Drug Evaluation and Clinical Research of Guangdong Pharmaceutical Association organized domestic experts to establish a working group on the

Consensus on the whole-process pharmaceutical care for iodine contrast medium

. The working group conducted literature searches， evidence-based analysis， and discussions on the development process， indications， contraindications， adverse drug reactions， drug interactions， drug use for special population， pharmaceutical care， and other key topics to summarize the content and process of the whole-process pharmaceutical care for iodine contrast medium. This consensus was ultimately formed.

RESULTS

The consensus on whole-process pharmaceutical care for iodine contrast medium included an evaluation of the patient， renal function， combined drug use， and hydration regimen before examination， the presence of contrast agent extravasation or suspected acute adverse reactions during examination， observation time points and follow-up after examination， and the presentation of specific work in each stage through pharmaceutical care flowchart. The medication monitoring record form was also formed to record the work situation.

CONCLUSIONS

The consensus has established a whole-process pharmaceutical care system for iodine contrast medium， providing scientific evidence for clinical physicians and nursing staff in the rational use of such special drugs， and also serving as a reference for pharmacists in providing related pharmaceutical care.

关键词

碘对比剂合理用药药物不良反应药学服务全流程共识

Keywords

rational drug useadverse drug reactionspharmaceutical carewhole-processconsensus

references

毛燕君，李玉梅，曾小红.碘对比剂静脉注射护理实践手册[M].上海：上海科学技术出版社，2020：12-16.

MAO Y J，LI Y M，ZENG X H. Nursing practice manual for intravenous injection of iodine contrast agent[M]. Shanghai：Shanghai Scientific & Technical Publishers，2020：12-16.

ACR Committee on Drugs and Contrast Media. ACR manual on contrast media.[M]. 2023 edition. Washington：American College of Radiology，2021：5-55.

Radiology European Society of Urogenital. ESUR guidelines on contrast agents[M]. Vienna：ESUR Guidelines on Contrast Agents，2018：6-30.

中华医学会临床药学分会，中国药学会医院药学专业委员会，中华医学会肾脏病学分会. 碘对比剂诱导的急性肾损伤防治的专家共识[J].中华肾脏病杂志，2022，38（3）：265-288.

Chinese Society of Clinical Pharmacy，Hospital Pharmacy Committee of the Chinese Pharmaceutical Association，Nephrology Branch of the Chinese Medical Association.Expert consensus on prevention and treatment of iodine contrast media-induced acute kidney injury[J]. Chin J Nephrol，2022，38（3）：265-288.

WEI Y，HE Z，ZHANG C，et al. Cost-minimization analysis of multidose and single-dose packaging of contrast media for contrast-enhanced CT：results from real-world data in China[J]. AJR Am J Roentgenol，2020，215：（1）：5-14.

MACDONALD D B，HURRELL C D，COSTA A F，et al. Canadian Association of Radiologists guidance on contrast-associated acute kidney injury[J]. Can J Kidney Health Dis，2022，9：20543581221097455.

PERNER A，PROWLE J，JOANNIDIS M，et al. Fluid management in acute kidney injury[J]. Intensive Care Med，2017，43（6）：807-815.

WHITING P，MORDEN A，TOMLINSON L A，et al. What are the risks and benefits of temporarily disconti- nuing medications to prevent acute kidney injury? A systematic review and meta-analysis[J]. BMJ Open，2017，7（4）：e012674.

ORLACCHIO A，GUASTONI C，BERETTA G D，et al. SIRM-SIN-AIOM：appropriateness criteria for evaluation and prevention of renal damage in the patient undergoing contrast medium examinations-consensus statements from Italian College of Radiology （SIRM），Italian College of Nephrology （SIN） and Italian Association of Medical Oncology （AIOM）[J]. Radiol Med，2022，127（5）：534-542.

HWANG E J，SHIN C I，CHOI Y H，et al. Frequency，outcome，and risk factors of contrast media extravasation in 142 651 intravenous contrast-enhanced CT scans[J]. Eur Radiol，2018，28（12）：5368-5375.

PLUMB A A，MURPHY G. The use of central venous catheters for intravenous contrast injection for CT examinations[J]. Br J Radiol，2011，84（999）：197-203.

中华医学会放射学分会对比剂安全使用工作组. 碘对比剂使用指南：第2版[J].中华医学杂志，2014，94（43）：3363-3369.

Contrast Media Safety Committee of the Radiology Branch of the Chinese Medical Association. Guide to the use of iodine contrast agents：2nd edition [J]. Natl Med J China，2014，94（43）：3363-3369.

YAMAGUCHI K，KATAYAMA H，TAKASHIMA T， et al. Prediction of severe adverse reactions to ionic and nonionic contrast media in Japan：evaluation of pretesting. A report from the Japanese Committee on the Safety of Contrast Media[J]. Radiology，1991，178（2）：363-367.

LASSER E C，BERRY C C，MISHKIN M M，et al. Pretreatment with corticosteroids to prevent adverse reactions to nonionic contrast media[J]. AJR Am J Roentgenol，1994，162（3）：523-526.

DAVENPORT M S，KHALATBARI S，COHAN R H， et al. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material：risk stratification by using estimated glomerular filtration rate[J]. Radiology，2013，268（3）：719-728.

MCDONALD R J，MCDONALD J S，BIDA J P，et al. Intravenous contrast material-induced nephropathy：causal or coincident phenomenon?[J]. Radiology，2016，278（1）：306.

MCDONALD J S，MCDONALD R J，CARTER R E， et al. Risk of intravenous contrast material-mediated acute kidney injury：a propensity score-matched study stratified by baseline-estimated glomerular filtration rate[J]. Radiology，2014，271（1）：65-73.

中华医学会放射学分会质量控制与安全管理专业委员会. 肾病患者静脉注射碘对比剂应用专家共识[J]. 中华放射学杂志，2021，55（6）：580-590.

Quality Control and Safety Management Committee of the Radiology Branch of the Chinese Medical Association.Expert consensus of iodinated contrast agent use in patients with renal diseases[J]. Chin J Radiol，2021，55（6）：580-590.

HIREMATH S，AKBARI A，SHABANA W，et al. Prevention of contrast-induced acute kidney injury：is simple oral hydration similar to intravenous? A systematic review of the evidence[J]. PLoS One，2013，8（3）：e60009.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

钆对比剂全程化药学服务共识

对炎症性肠病患者开展抗TNF-α制剂TDM的国内外指南/共识的质量评价

基于临床治疗指南及共识的住院患者多黏菌素B应用分析与评价

上海市金山区居家严重精神障碍患者用药依从性影响因素及药物不良反应调查分析 ^Δ